Agilon Health Inc. (NYSE: AGL) reported Q3 EPS of ($0.29), $0.19 worse than the analyst estimate of ($0.10). Revenue for the quarter came in at $1.45 billion versus the consensus estimate of $1.47 billion.

GUIDANCE:

Agilon Health Inc. sees FY2024 revenue of $6.05-6.06 billion, versus the consensus of $6.02 billion.

Agilon Health Inc. sees Q4 2024 revenue of $1.51-1.52 billion, versus the consensus of $1.46 billion.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.